Drugs / BioDFence G3 Placental Tissue Membrane
BioDFence G3 Placental Tissue Membrane
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05842057 | Aug 2023 → Aug 2027 expected | prostate cancer | University of Miami | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioDFence G3 Placental Tissue Membrane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05842057 ↗ |
| Modality | Other / unclassified | “The BioDFence G3 Placental Tissue Membrane is a three-layer tissue allograft” NCT05842057 ↗ |
| Route | Other | “Amniotic membranes will be placed over the neurovascular bundle after extirpative RARP.” NCT05842057 ↗ |